ClinConnect ClinConnect Logo
Search / Trial NCT04532398

Validation of the Gugging Swallowing Screen for the Intensive Care Unit

Launched by UNIVERSITY HOSPITAL, BASEL, SWITZERLAND · Aug 25, 2020

Trial Information

Current as of May 03, 2025

Completed

Keywords

Gugging Swallowing Screen Icu (Guss Icu) Gugging Swallowing Screen (Guss) Multi Consistency Check Flexible Endoscopic Evaluation Of Swallowing (Fees)

ClinConnect Summary

Aetiology of dysphagia after extubation is unknown and considered to be multifactorial. Use of a standardized dysphagia- screening permits an early diagnosis. This study is to evaluate a new GUSS (gugging swallowing Screen) tool with multi-consistency check for intensive care patients (GUSS-ICU) with dysphagia. The concurrent validity (in terms of sensitivity and specificity) of the GUSS-ICU is analyzed in comparison to the flexible endoscopic evaluation of swallowing (FEES).

The GUSS-ICU with multi-consistency check includes an indirect and a direct swallowing attempt. In indirect swallow...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • patients treated in ICU with intubation time of at least 24 hours
  • Richmond Agitation-Sedation Scale (RASS)-Score of 0 (alert and calm) to 2 (agitated)
  • Inclusion in study not earlier than 1 hour after extubation
  • Mini-Mental-State (MMS) Score \>/=24
  • signed informed consent
  • Exclusion Criteria:
  • not capable to follow study procedures (language problems, mental disorder)
  • end of life- patients

About University Hospital, Basel, Switzerland

The University Hospital Basel, Switzerland, is a leading academic medical center renowned for its commitment to cutting-edge research and innovative patient care. As a prominent clinical trial sponsor, the hospital leverages its extensive expertise and state-of-the-art facilities to advance medical knowledge and therapeutic options across various disciplines. With a collaborative approach that integrates clinical practice and scientific inquiry, the University Hospital Basel fosters an environment conducive to rigorous clinical trials, ensuring the highest standards of safety and efficacy. Its strategic focus on patient-centered research aims to translate scientific discoveries into tangible health solutions, benefiting both local and global communities.

Locations

Basel, , Switzerland

Patients applied

0 patients applied

Trial Officials

Claudia Troll

Principal Investigator

Logopädie (speech therapy), University Hospital Basel

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials